Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Transpact Enterprises Ltd. is significantly underperforming in key financial metrics compared to its peers in the Medical Equipment sector. The company shows no revenue or earnings growth, lacks profitability, and has an extremely high P/E ratio, indicating it is overvalued. In contrast, Poly Medicure Ltd. stands out as a strong performer with robust growth, solid profitability, and attractive valuation metrics.
Strong revenue growth (21.37% YoY) and solid profitability metrics (ROE 16.01%).
Good profitability with ROE of 18.70% and low valuation metrics (PE 37.56).
High ROE of 96.95%, although with a high debt-equity ratio.